Genetic heterogeneity in partial adenosine deaminase deficiency. 1983

R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins

Inherited deficiency of the enzyme adenosine deaminase (ADA) results in a syndrome of severe combined immunodeficiency (SCID). Children with ADA- -SCID lack ADA in all cells and tissues. In contrast, a "partial" deficiency of ADA has been described in six immunologically normal children from four different "families." These children lack ADA in their erythrocytes but retain variable amounts of activity in their lymphoid cells. We have examined ADA activity in lymphoid line cells from four of these children, who are unrelated, for evidence of genetic heterogeneity. One child, who is Caucasian, has an enzyme with increased electrophoretic mobility, a diminished isoelectric point (pI 4.8 vs. Nl = 4.9) and very low activity (2.3 vs. Nl = 82.9 +/- 12.9 nmol/mg protein per min); as a second child has an enzyme with normal electrophoretic mobility but increased isoelectric point (pI = 5.0), markedly diminished heat stability at 56 degrees C (t1/2 = 4.2' vs. Nl = 40') and low activity (12.1); a third has an enzyme with only diminished heat stability (t1/2 = 6.5'), no detectable abnormality in charge and almost normal activity (41.9); while the fourth exhibits only diminished ADA activity (25.0) with no striking qualitative abnormalities. Thus, we have found evidence for three different mutations at the structural locus for ADA in three of these individuals, (a) an acidic, low activity heat stable mutation (b) a basic, somewhat higher activity, heat labile mutation, and (c) a relatively normal activity heat labile mutation. In the fourth, there is as yet no compelling evidence for a mutation at the structural locus for ADA and a mutation at a regulatory locus cannot be excluded.

UI MeSH Term Description Entries
D007526 Isoelectric Point The pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum. Isoelectric Points,Point, Isoelectric,Points, Isoelectric
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004592 Electrophoresis, Starch Gel Electrophoresis in which a starch gel (a mixture of amylose and amylopectin) is used as the diffusion medium. Starch Gel Electrophoresis
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic

Related Publications

R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
January 1986, American journal of human genetics,
R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
January 1998, Ryoikibetsu shokogun shirizu,
R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
February 1994, The Journal of allergy and clinical immunology,
R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
November 1986, Human genetics,
R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
January 1998, Ryoikibetsu shokogun shirizu,
R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
June 1987, Hospital practice (Office ed.),
R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
January 2000, Ryoikibetsu shokogun shirizu,
R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
January 1990, Immunodeficiency reviews,
R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
May 1978, Nihon rinsho. Japanese journal of clinical medicine,
R Hirschhorn, and F Martiniuk, and V Roegner-Maniscalco, and A Ellenbogen, and J L Perignon, and T Jenkins
January 2001, Ryoikibetsu shokogun shirizu,
Copied contents to your clipboard!